Saturday 17 October 2026 Export ANIP’s income statement to Excel — free account

ANI Pharmaceuticals, Inc.

ANIP Healthcare Drug Manufacturers Specialty & Generic

ANI Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $883.4 million, up 43.8% from fiscal 2024. In the quarter to June 2026, revenue grew 25.9%, EPS grew 194.6%, free cash flow fell 22.2% and total debt fell 1.78%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

72.08 0.20 −0.28%

Follow ANIP

Alert me

Market cap: $1.7B
P/E: 14.9×
Fwd P/E: 14.5×
Dividend yield: —
F-score: 7/9
Altman Z: 2.30
Beneish M: −2.62
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	17.14	18.71	22.55	53.57	+8 more quarters Free account
P/S ratio Full definition →	1.79	1.74	1.79	2.22
P/FCF ratio Full definition →	10.46	8.80	10.49	13.59
P/Operating CF Full definition →	30.91	27.55	52.13	41.74
P/B ratio Full definition →	2.93	2.86	2.93	3.64
Price to Tangible BV Full definition →	20.64	49.24	0.00	0.00
EV/Sales Full definition →	2.03	2.05	2.16	2.65
EV/EBITDA Full definition →	8.41	8.89	9.41	12.59
EV/Operating CF Full definition →	10.48	9.09	10.29	12.81
EV/FCF Full definition →	11.86	10.37	12.63	16.17
Quick Ratio Full definition →	2.29	2.43	2.07	1.94
Current Ratio Full definition →	2.91	3.12	2.71	2.58
Net Debt/EBITDA Full definition →	3.90	4.81	5.62	5.92
Debt/Assets Full definition →	40.86%	43.16%	42.84%	44.05%
Debt/Equity Full definition →	1.02	1.09	1.14	1.23
Asset Turnover Full definition →	0.69	0.68	0.65	0.61
Operating CF/Net income Full definition →	2.29	1.98	1.10	1.68
Capex/Depreciation Full definition →	(0.16)	(0.54)	(0.06)	(0.27)
Interest Coverage Full definition →	11.13	10.32	7.88	7.67
Research and Development Expense of Revenue Full definition →	5.54%	4.46%	4.96%	5.40%
Selling, General and Administrative Expense of Revenue Full definition →	34.45%	31.02%	33.51%	33.65%
Intangible Assets out of Total Assets Full definition →	0.34	0.37	0.38	0.40
Share Based Compensation of Revenue Full definition →	4.29%	4.29%	3.95%	4.25%
Graham Net Nets Full definition →	(0.04)	(0.07)	(0.09)	(0.11)
Graham Number Full definition →	55.39	49.86	46.08	31.14
Earnings Yield Full definition →	5.83%	5.34%	4.43%	1.87%
Free Cash Flow Yield Full definition →	9.56%	11.37%	9.53%	7.36%
Revenue per Share Full definition →	12.57	11.35	12.32	11.35
Operating CF per Share Full definition →	2.68	2.79	1.51	2.19
Capex per Share Full definition →	(0.14)	(0.54)	(0.07)	(0.31)
Free Cash Flow per Share Full definition →	2.53	2.25	1.44	1.89
Cash per Share Full definition →	17.77	15.59	14.70	13.53
Shareholders Equity per Share Full definition →	28.23	26.89	26.96	25.20
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	28.23	26.89	26.96	25.20
Free Cash Flow Full definition →	53.62	47.05	28.96	37.89
Working Capital Full definition →	541.78	507.57	475.01	427.85
Capital Expenditures Full definition →	(3.05)	(11.32)	(1.40)	(6.16)
Net Current Asset Value Full definition →	(71.47)	(112.59)	(146.54)	(203.93)
EV/EBIT Full definition →	13.21	15.32	17.15	30.41
Capex to Sales Full definition →	0.01	0.05	0.01	0.03
Price to Operating Income Full definition →	11.65	12.99	14.25	25.56
Other line items
Average Receivables Full definition →	250.06	237.88	251.40	224.49
Average Payables Full definition →	64.20	61.38	54.12	65.34
Average Inventory Full definition →	140.73	140.44	139.92	147.26
Average Assets Full definition →	1,418.56	1,357.20	1,362.42	1,347.76
Average Common Equity Full definition →	516.98	490.46	472.20	455.88

Show all line items

Columns are period end dates

Stockrow Weekly